Christina Grek to Connexin 43
This is a "connection" page, showing publications Christina Grek has written about Connexin 43.
Connection Strength
3.609
-
Novel approach to temozolomide resistance in malignant glioma: connexin43-directed therapeutics. Curr Opin Pharmacol. 2018 08; 41:79-88.
Score: 0.567
-
A Multicenter Randomized Controlled Trial Evaluating a Cx43-Mimetic Peptide in Cutaneous Scarring. J Invest Dermatol. 2017 03; 137(3):620-630.
Score: 0.510
-
Connexin 43, breast cancer tumor suppressor: Missed connections? Cancer Lett. 2016 Apr 28; 374(1):117-126.
Score: 0.484
-
Topical administration of a connexin43-based peptide augments healing of chronic neuropathic diabetic foot ulcers: A multicenter, randomized trial. Wound Repair Regen. 2015 Mar-Apr; 23(2):203-12.
Score: 0.458
-
Targeting connexin 43 with a-connexin carboxyl-terminal (ACT1) peptide enhances the activity of the targeted inhibitors, tamoxifen and lapatinib, in breast cancer: clinical implication for ACT1. BMC Cancer. 2015 Apr 03; 15:296.
Score: 0.456
-
Cardiac to cancer: connecting connexins to clinical opportunity. FEBS Lett. 2014 Apr 17; 588(8):1349-64.
Score: 0.423
-
The connexin 43 carboxyl terminal mimetic peptide aCT1 prompts differentiation of a collagen scar matrix in humans resembling unwounded skin. FASEB J. 2021 08; 35(8):e21762.
Score: 0.177
-
Development of PLGA nanoparticles for sustained release of a connexin43 mimetic peptide to target glioblastoma cells. Mater Sci Eng C Mater Biol Appl. 2020 Mar; 108:110191.
Score: 0.155
-
Connexin 43-Based Therapeutics for Dermal Wound Healing. Int J Mol Sci. 2018 06 15; 19(6).
Score: 0.142
-
Targeting the tight junction protein, zonula occludens-1, with the connexin43 mimetic peptide, aCT1, reduces VEGF-dependent RPE pathophysiology. J Mol Med (Berl). 2017 05; 95(5):535-552.
Score: 0.129
-
The effect of a connexin43-based Peptide on the healing of chronic venous leg ulcers: a multicenter, randomized trial. J Invest Dermatol. 2015 Jan; 135(1):289-298.
Score: 0.109